BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paakinaho V, Lempiäinen JK, Sigismondo G, Niskanen EA, Malinen M, Jääskeläinen T, Varjosalo M, Krijgsveld J, Palvimo JJ. SUMOylation regulates the protein network and chromatin accessibility at glucocorticoid receptor-binding sites. Nucleic Acids Res 2021;49:1951-71. [PMID: 33524141 DOI: 10.1093/nar/gkab032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Vertegaal ACO. Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol 2022. [PMID: 35750927 DOI: 10.1038/s41580-022-00500-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Budziñski ML, Sokn C, Gobbini R, Ugo B, Antunica-Noguerol M, Senin S, Bajaj T, Gassen NC, Rein T, Schmidt MV, Binder EB, Arzt E, Liberman AC. Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity. Mol Psychiatry 2022. [PMID: 35256747 DOI: 10.1038/s41380-022-01491-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Du L, Liu W, Aldana-Masangkay G, Pozhitkov A, Pichiorri F, Chen Y, Rosen ST. SUMOylation inhibition enhances dexamethasone sensitivity in multiple myeloma. J Exp Clin Cancer Res 2022;41:8. [PMID: 34983615 DOI: 10.1186/s13046-021-02226-9] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
4 Fernández-Serrano M, Winkler R, Santos JC, Le Pannérer MM, Buschbeck M, Roué G. Histone Modifications and Their Targeting in Lymphoid Malignancies. Int J Mol Sci 2021;23:253. [PMID: 35008680 DOI: 10.3390/ijms23010253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Alendar A, Berns A. Sentinels of chromatin: chromodomain helicase DNA-binding proteins in development and disease. Genes Dev 2021;35:1403-30. [PMID: 34725129 DOI: 10.1101/gad.348897.121] [Reference Citation Analysis]
6 Baig MS, Dou Y, Bergey BG, Bahar R, Burgener JM, Moallem M, McNeil JB, Akhter A, Burke GL, Sri Theivakadadcham VS, Richard P, D'Amours D, Rosonina E. Dynamic sumoylation of promoter-bound general transcription factors facilitates transcription by RNA polymerase II. PLoS Genet 2021;17:e1009828. [PMID: 34587155 DOI: 10.1371/journal.pgen.1009828] [Reference Citation Analysis]
7 Wang Y, Yu J. Dissecting multiple roles of SUMOylation in prostate cancer. Cancer Lett 2021;521:88-97. [PMID: 34464672 DOI: 10.1016/j.canlet.2021.08.034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hu X, Liu Z, Duan X, Han X, Yuan M, Liu L, Xia X, Li N, Qin J, Wang Y. Blocking MCT4 SUMOylation inhibits the growth of breast cancer cells. Mol Carcinog 2021. [PMID: 34347919 DOI: 10.1002/mc.23336] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Paakinaho V, Palvimo JJ. Genome-wide crosstalk between steroid receptors in breast and prostate cancers. Endocr Relat Cancer 2021;28:R231-50. [PMID: 34137734 DOI: 10.1530/ERC-21-0038] [Cited by in F6Publishing: 2] [Reference Citation Analysis]